Rodney Plaskett
About Rodney Plaskett
Rodney Plaskett is a Managing Director with extensive experience in investment and financial services, currently working at Waypoint Residential and Third Seven Capital. He has held various senior roles at notable firms, including Sidoti & Company and Oppenheimer & Co., and possesses a strong background in both traditional and alternative investment strategies.
Current Role at Waypoint Residential
Rodney Plaskett serves as the Managing Director at Waypoint Residential, a position he has held since 2021. He operates from Stamford, Connecticut, where he applies his extensive experience in investment strategies to guide the company's residential investment initiatives.
Previous Experience in Financial Services
Rodney Plaskett has held multiple senior roles in the financial services industry. He worked at Sidoti & Company as Institutional Sales from 2016 to 2018, and at Oppenheimer & Co. Inc. as Director of Investments from 2014 to 2016. His career also includes positions at Fortis Lux Financial, Maxim Group, and Bank of America, showcasing a diverse background in investment management.
Educational Background
Rodney Plaskett earned a Bachelor of Arts degree in History from Franklin & Marshall College, where he studied from 1973 to 1977. He furthered his education at Columbia Law School, obtaining a Doctor of Law (J.D.) from 1977 to 1981. This academic foundation supports his extensive career in finance and law.
Investment Strategy and Expertise
Rodney Plaskett possesses a deep understanding of both traditional and alternative investment strategies. His expertise includes real estate, hedge funds, private equity, private debt, and venture capital. He combines these strategies to provide a well-rounded perspective for assisting investors with allocation decisions.
Capital Raising Experience
Rodney Plaskett has extensive experience in raising debt and equity capital for both early-stage and late-stage private companies. His work spans various sectors, including information technology, biopharmaceuticals, medical devices, renewable energy, and real estate, reflecting a broad knowledge of the investment landscape.